Differential SERCA Expression in Laryngeal Muscles

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

January 25, 2025

Study Completion Date

February 1, 2025

Conditions
Myopathy
Interventions
DIAGNOSTIC_TEST

Immunohistochemistry (IHC)

We faced unsuccessful fast fiber type's identification on frozen sections then we shifted to paraffin sections. Deparaffinized sections were incubated with 3% H2O2 in PBS for 10 minutes followed by microwave treatment (5 minutes ×3 times at 500 Watt in citrate buffer, pH 6). Then, sections were incubated in blocking solution (0.3 M glycine, 50 mM ammonium chloride, and 1% BSA in PBS) for 30 minutes before incubation in primary antibodies. Sections were incubated with anti-SERCA1 or -SERCA2 and anti-MHC I or -MHCII (Table 1) antibodies for 1-2 days at 4 ◦C, then washed, and incubated with Alexa Fluor® 488 donkey anti-mouse IgG and Fluor® 594 donkey anti-goat IgG secondary Abs for 1 hour at room temperature. Double IHC was performed using (anti-SERCA1 + anti-SERCA2) and (anti-SERCA2 + anti-MHCII) combinations to check co-expression. In double IHC, the same steps were done as before with mixture of primary or secondary antibodies with same dilutions.

Trial Locations (1)

82524

Sohag University, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06837467 - Differential SERCA Expression in Laryngeal Muscles | Biotech Hunter | Biotech Hunter